The year 2025 saw a sharp rise in health care spending in the United States, primarily influenced by the growing use of GLP-1 medications.
In addition to the popularity of these drugs, there has been an overall increase in the amount of care people are receiving.
This combination of factors has led to significant changes in health spending patterns, reflecting evolving health care needs and treatment options.